Citation Impact
Citing Papers
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
2014 Standout
Preoperative pharmacological management of phaeochromocytoma.
2006
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma
2011
Optimal Management of the T1G3 Bladder Cancer
2005
Risk of tumorigenesis in overgrowth syndromes: A comprehensive review
2005
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
Recent developments in the therapy of phaeochromocytoma
2004
Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy
2003
Phaeochromocytoma
2005 Standout
Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells
2010
Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review
2005
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
2012
The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas
2005
von Hippel-Lindau disease
2003 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder cancer
2016 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Per-operative Hemodynamic Instability in Normotensive Patients With Incidentally Discovered Pheochromocytomas
2014
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
A meta‐analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia
2004
A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
2010
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Pheochromocytoma: presentation, diagnosis and treatment
2006
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients
2008
Cancer vaccines 2003: opening address.
2003
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Initial Tumor Stage and Grade as a Predictive Factor for Recurrence in Patients With Stage T1 Grade 3 Bladder Cancer
2004
ESC Council on hypertension position document on the management of hypertensive emergencies
2018
Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?
2006
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Laparoscopic Management of Extra-Adrenal Pheochromocytoma
2004
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of P. Ballanger being referenced
Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years
2001
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers
2009
Laparoscopic Surgery for Pheochromocytoma
2003
Effects of perioperative α 1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma
2004
Evaluation of the Transurethral Ethanol Ablation of the Prostate (TEAP) for Symptomatic Benign Prostatic Hyperplasia (BPH): A European Multi-Center Evaluation
2004
Successful laparoscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome
2002
[Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate].
2005
Assessment of serum catecholamine concentrations in patients with pheochromocytoma undergoing videolaparoscopic adrenalectomy
2005
Clinical and Urodynamic Repercussions after TVT Procedure and How to Diminish Patient Complaints
2003